PT1235571E - Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino - Google Patents

Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino

Info

Publication number: PT1235571E
Authority: PT; Portugal
Prior art keywords: melatonin; androgenetic; treatment; diffuse; alope
Prior art date: 1999-11-30

Application number

PT00993238T

Other languages

English (en)

Inventor

Peter Elsner

Original Assignee

Asat Ag Applied Science & Tech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-30

Filing date

2000-11-29

Publication date

2004-12-31

2000-11-29 Application filed by Asat Ag Applied Science & Tech filed Critical Asat Ag Applied Science & Tech

2004-12-31 Publication of PT1235571E publication Critical patent/PT1235571E/pt

Links

YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title abstract 3
DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title abstract 3
229960003987 melatonin Drugs 0.000 title abstract 3
241000828883 Alope Species 0.000 title 1
201000004384 Alopecia Diseases 0.000 abstract 1
208000003024 Diffuse alopecia Diseases 0.000 abstract 1
206010068168 androgenetic alopecia Diseases 0.000 abstract 1
201000002996 androgenic alopecia Diseases 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens

PT00993238T 1999-11-30 2000-11-29 Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino PT1235571E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19957710A DE19957710A1 (de)	1999-11-30	1999-11-30	Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US09/506,442 US6281241B1 (en)	1999-11-30	2000-02-18	Use of melatonin for the treatment of androgenetic alopecia

Publications (1)

Publication Number	Publication Date
PT1235571E true PT1235571E (pt)	2004-12-31

Family

ID=7930930

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT00993238T PT1235571E (pt)	1999-11-30	2000-11-29	Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino

Country Status (12)

Country	Link
US (2)	US6281241B1 (pt)
EP (1)	EP1235571B1 (pt)
JP (1)	JP4713805B2 (pt)
AT (1)	ATE275400T1 (pt)
AU (1)	AU2838101A (pt)
CA (1)	CA2392620C (pt)
DE (2)	DE19957710A1 (pt)
DK (1)	DK1235571T3 (pt)
ES (1)	ES2228663T3 (pt)
PT (1)	PT1235571E (pt)
TR (1)	TR200402628T4 (pt)
WO (1)	WO2001039771A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19957710A1 (de) *	1999-11-30	2001-05-31	Asat Ag Applied Science & Tech	Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US7015072B2 (en)	2001-07-11	2006-03-21	Asat Limited	Method of manufacturing an enhanced thermal dissipation integrated circuit package
US6734552B2 (en)	2001-07-11	2004-05-11	Asat Limited	Enhanced thermal dissipation integrated circuit package
US6790710B2 (en) *	2002-01-31	2004-09-14	Asat Limited	Method of manufacturing an integrated circuit package
US20030178719A1 (en) *	2002-03-22	2003-09-25	Combs Edward G.	Enhanced thermal dissipation integrated circuit package and method of manufacturing enhanced thermal dissipation integrated circuit package
US6940154B2 (en) *	2002-06-24	2005-09-06	Asat Limited	Integrated circuit package and method of manufacturing the integrated circuit package
JP2006510556A (ja) *	2002-10-30	2006-03-30	アサト　アクチェンゲゼルシャフト　アプライド　サイエンス　アンド　テクノロジー	メラトニン−日用量ユニット
US20050249785A1 (en) *	2003-08-13	2005-11-10	Gordon John G	Use of melatonin-containing oral supplement with animals
WO2005082143A1 (en) *	2004-02-20	2005-09-09	Lifescape Biosciences Incorporated	Compositions and methods for sleep regulation
JP3964417B2 (ja) *	2004-09-27	2007-08-22	国立大学法人金沢大学	インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤
US20080059313A1 (en) *	2006-08-30	2008-03-06	Oblong John E	Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
ITGE20070009A1 (it) *	2007-01-24	2008-07-25	Leila Baeram	Composizione cosmetica e metodo per favorire la ricrescita dei capelli.
US20100120871A1 (en) *	2008-11-10	2010-05-13	Dawson Jr Thomas Larry	Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
GB0918564D0 (en)	2009-10-22	2009-12-09	Plasticell Ltd	Nested cell encapsulation
WO2011109459A2 (en) *	2010-03-04	2011-09-09	University Of Miami	Compositions, kits and methods for determining efficacy of a therapeutic agent and treating hair and skin diseases
ITMI20112432A1 (it) *	2011-12-30	2013-07-01	Bionest Ltd	Kit per il trattamento e la prevenzione dell'alopecia
US11696883B2 (en)	2014-05-23	2023-07-11	Triple Hair Inc.	Compositions for reducing hair loss and/or increasing hair regrowth
EP3062797B1 (en)	2014-05-23	2019-08-28	Triple Hair Inc.	Compositions for reducing hair loss and/or increasing hair regrowth
ES2902842T3 (es)	2015-07-08	2022-03-30	Triple Hair Inc	Composición que comprende resveratrol y melatonina para reducir la caída y/o aumentar el crecimiento del cabello
WO2017178250A1 (en)	2016-04-11	2017-10-19	Vytrus Biotech, S.L.	Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment
GB201707143D0 (en)	2017-05-04	2017-06-21	Plasticell Ltd	Method for producing cells

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5340579A (en) *	1984-11-20	1994-08-23	Farmaka S.R.L.	Method of treating dermatological conditions
US4746674A (en)	1985-08-27	1988-05-24	Cellena (Cell Engineering) Ag	Melatonin compositions and uses thereof
JPS61212512A (ja) *	1985-03-19	1986-09-20	Shiseido Co Ltd	養毛料
US4945103A (en) *	1989-01-17	1990-07-31	Michael Cohen	Method of treating pre-menstrual syndrome
FR2717381B1 (fr) *	1994-03-15	1996-04-19	Oreal	Compositions à base d'alpha-pyrones pour induire et stimuler la croissance des cheveux et/ou freiner leur chute et utilisation.
JP3108586B2 (ja) *	1994-06-01	2000-11-13	富士産業株式会社	育毛剤
US5597575A (en) *	1994-06-06	1997-01-28	Breitbarth; Richard	Composition for stimulating and inducing hair growth
DE19509354A1 (de) *	1994-12-08	1996-06-13	Klett Loch Lore M	Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall
US5792785A (en) *	1995-11-24	1998-08-11	Equitech Laboratories, Inc.	Method for enhancing pregnancy success in an animal
ES2101660B1 (es) *	1995-12-21	1997-12-16	Soler Armando Jose Yanez	Nuevo crecepelo de uso topico.
GB2314019B (en) *	1996-06-10	2000-03-15	Bio Scient Ltd	The use of L-Lysine in the treatment of hair loss
FR2751539B1 (fr) *	1996-07-25	1998-12-04	Oreal	Nouvelles compositions topiques comprenant de tres faibles doses de melatonine ou ses derives et leur utilisation en cosmetique
WO1998005298A1 (es) *	1996-08-02	1998-02-12	Universidad De Granada	Desarrollo de productos cosmeticos para uso humano a base de melatonina como producto activo
FR2754454B1 (fr) *	1996-10-10	1998-11-27	Oreal	Utilisation d'au moins un glycol comme agent de solubilisation de la melatonine dans l'eau et compositions obtenues
FR2756832B1 (fr) *	1996-12-06	1999-01-08	Oreal	Utilisation de melatonine dans une composition pour stabiliser les polymeres gelifiants hydrophiles
US5958964A (en) *	1997-02-18	1999-09-28	South Alabama Medical Science Foundation	Use of melatonin to prevent cytotoxic effects of amyloid beta protein
US6030948A (en) *	1997-12-19	2000-02-29	Mann; Morris A.	Hair regeneration compositions for treatment of alopecia and methods of application related thereto
US6274615B1 (en) *	1998-03-25	2001-08-14	South Alabama Medical Science Foundation	Method for delaying the onset of alheimer's disease and for treatment or delaying the onset of other amyloidosis-related diseases/disorders
DE19957710A1 (de) *	1999-11-30	2001-05-31	Asat Ag Applied Science & Tech	Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US6747008B1 (en) *	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
FR2811550B1 (fr) *	2000-07-11	2003-02-14	Oreal	Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux

1999
- 1999-11-30 DE DE19957710A patent/DE19957710A1/de not_active Ceased
2000
- 2000-02-18 US US09/506,442 patent/US6281241B1/en not_active Expired - Lifetime
- 2000-11-29 CA CA002392620A patent/CA2392620C/en not_active Expired - Fee Related
- 2000-11-29 AT AT00993238T patent/ATE275400T1/de active
- 2000-11-29 PT PT00993238T patent/PT1235571E/pt unknown
- 2000-11-29 JP JP2001541503A patent/JP4713805B2/ja not_active Expired - Fee Related
- 2000-11-29 DK DK00993238T patent/DK1235571T3/da active
- 2000-11-29 ES ES00993238T patent/ES2228663T3/es not_active Expired - Lifetime
- 2000-11-29 US US10/130,297 patent/US20020183377A1/en not_active Abandoned
- 2000-11-29 AU AU28381/01A patent/AU2838101A/en not_active Abandoned
- 2000-11-29 DE DE50007706T patent/DE50007706D1/de not_active Expired - Lifetime
- 2000-11-29 EP EP00993238A patent/EP1235571B1/de not_active Expired - Lifetime
- 2000-11-29 WO PCT/EP2000/011976 patent/WO2001039771A1/de active Search and Examination
- 2000-11-29 TR TR2004/02628T patent/TR200402628T4/xx unknown

Also Published As

Publication number	Publication date
JP2004500353A (ja)	2004-01-08
US6281241B1 (en)	2001-08-28
JP4713805B2 (ja)	2011-06-29
CA2392620A1 (en)	2001-06-07
ES2228663T3 (es)	2005-04-16
CA2392620C (en)	2009-10-13
US20020183377A1 (en)	2002-12-05
AU2838101A (en)	2001-06-12
EP1235571A1 (de)	2002-09-04
DE19957710A1 (de)	2001-05-31
ATE275400T1 (de)	2004-09-15
DE50007706D1 (de)	2004-10-14
EP1235571B1 (de)	2004-09-08
DK1235571T3 (da)	2005-01-17
TR200402628T4 (tr)	2004-11-22
WO2001039771A1 (de)	2001-06-07

Publication	Publication Date	Title
PT1235571E (pt)	2004-12-31	Utilizacao de melatonina para o tratamento da alopecia androgenetica e difusa do tipo feminino
NO20014560L (no)	2001-09-19	Quinasoliner og terapautisk anvendelse derav
WO2001085106A3 (de)	2002-08-01	Kosmetisches mittel enthaltend 2-furanonderivate
HK1051005A1 (en)	2003-07-18	Methods and compositions for modulating alpha adrenergic receptor activity
MY155218A (en)	2015-09-30	Small molecules useful in the treatment of inflammatory disease
DK1373215T3 (da)	2006-11-13	Gelanamycinderivater egnet til behandling af cancer
GB9815177D0 (en)	1998-09-09	Treatment of skin disorders
HK1050860A1 (en)	2003-07-11	Nordihydroguaiaretic derivatives for use in treatment of tumors
AU5338401A (en)	2001-10-30	Methods and compositions for modulating alpha adrenergic receptor activity
BR9912327A (pt)	2001-05-02	Inibidores da uroquinase
TR200103819T2 (tr)	2002-04-22	kanser tedavisinde ET743 terkipleri ve kullanımları
MXPA04003674A (es)	2004-07-23	Uso mejorado de compuesto antitumoral en terapia de cancer.
MY138883A (en)	2009-08-28	Use of asiatic acid for treatment of cencer
DE60013486D1 (de)	2004-10-07	Verbindungen
AR020563A1 (es)	2002-05-15	Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
NO970178L (no)	1997-01-15	Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
TR200302134T4 (tr)	2004-01-21	2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
BR0015938A (pt)	2002-08-27	Uso de antagonistas beta-adrenoceptores para a fabricação de um medicamento para o tratamento de desordens da retina externa
MXPA02004699A (es)	2004-09-10	Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco.
EE200300057A (et)	2004-12-15	Koostis vähi profülaktikaks ja raviks
GB0312566D0 (en)	2003-07-09	Veterinary composition for the topical treatment of traumatized or inflamed skin
DE60120159D1 (de)	2006-07-06	Hautpflegemittel
DE50112512D1 (de)	2007-06-28	Phenanthridinderivate und phenanthridin enthaltende antitumorale arzneimittel
ATE321546T1 (de)	2006-04-15	Ppar-alpha,beta-aktivatoren zur behandlung von alopecia areata und vitiligo
ES2181160T3 (es)	2003-02-16	Derivados de 1,4-dihidropiridina y su utilizacion en terapia.